413 related articles for article (PubMed ID: 34899188)
1. Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention.
Zhang G; Wang Z; Hu H; Zhao M; Sun L
Front Cell Neurosci; 2021; 15():749587. PubMed ID: 34899188
[TBL] [Abstract][Full Text] [Related]
2. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
3. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
4. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
Xu YJ; Au NPB; Ma CHE
Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
[TBL] [Abstract][Full Text] [Related]
5. Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease.
Shen Z; Bao X; Wang R
Front Aging Neurosci; 2018; 10():314. PubMed ID: 30349474
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
[TBL] [Abstract][Full Text] [Related]
7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
8. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
Yang Y; Zhang Z
Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
[TBL] [Abstract][Full Text] [Related]
9. Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease.
Zhao Y; Liu B; Wang J; Xu L; Yu S; Fu J; Yan X; Su J
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892700
[TBL] [Abstract][Full Text] [Related]
10. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.
Uddin MS; Kabir MT; Al Mamun A; Behl T; Mansouri RA; Aloqbi AA; Perveen A; Hafeez A; Ashraf GM
Curr Pharm Des; 2021; 27(3):357-366. PubMed ID: 32473620
[TBL] [Abstract][Full Text] [Related]
11. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
12. Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target.
Wang Q; Yao H; Liu W; Ya B; Cheng H; Xing Z; Wu Y
Front Aging Neurosci; 2021; 13():772717. PubMed ID: 34819850
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia.
Agrawal I; Jha S
Front Aging Neurosci; 2020; 12():252. PubMed ID: 32973488
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
[TBL] [Abstract][Full Text] [Related]
15. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
16. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
[TBL] [Abstract][Full Text] [Related]
17. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
18. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
19. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
Wang WY; Tan MS; Yu JT; Tan L
Ann Transl Med; 2015 Jun; 3(10):136. PubMed ID: 26207229
[TBL] [Abstract][Full Text] [Related]
20. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
